Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Herbalife Nutrition Ltd (HLF) vs Jabil Inc (JBL) Price & Performance

Herbalife Nutrition LtdTrade

Price performance (Past 24H)

Key statistics

Herbalife Nutrition Ltd vs Jabil Inc — how do they compare? Herbalife Nutrition Ltd trades at $11.76 (market cap $1.23B), while Jabil Inc trades at $365.21 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 30.4× Herbalife Nutrition Ltd's market cap, and Jabil Inc pays a 0.09% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.

HLFJBL
Market Cap
$1.23B$37.37B
Sector
Consumer StaplesTechnology
52-Week High
$19.96$385.50
52-Week Low
$7.75$192.49
Enterprise Value
$3.06B$39.90B
Dividend Yield
0.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Herbalife Nutrition Ltd

Herbalife (HLF) trades at $11.695, up 1.52% on the day, with a bearish technical outlook per moving averages. The company reported Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, though EPS of $0.51 missed estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24. Positive news includes being named to TIME's America's Best Companies 2026 list, but a planned CFO transition in December 2026 introduces uncertainty.

The outlook is mixed; strong sales growth and low valuation metrics offer potential upside, but recent earnings misses, a high debt load, and negative shareholder equity pose significant risks. Analyst consensus leans bullish with 53.84% buy ratings, yet the stock faces headwinds from competitive pressures and margin volatility.

Jabil Inc

JBL trades at $368.37, up 9.43% with strong bullish momentum driven by AI infrastructure demand and recent earnings beats. The stock shows robust technical strength with moving averages signaling buy and price approaching resistance at $371. Fundamentally, revenue growth accelerated to $33.6B in 2026 with net profit margin improving to 2.56%, though valuation multiples remain elevated with P/E at 44.63.

Outlook remains positive with analyst consensus target of $448.29 (22% upside) and 50% buy ratings. Key opportunities include projected AI revenue growth to $20B+ by 2027, while risks include competitive pressures and the stock's premium valuation. Recent UBS upgrade to Buy highlights multi-year AI growth cycle potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Herbalife Nutrition Ltd

Herbalife Nutrition Ltd is an international nutrition company.

Read more on HLF

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.

Read more on JBL